Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 7906843, 9 pages
https://doi.org/10.1155/2017/7906843
Research Article

Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status

1Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan
2Department of Laboratory Medicine, National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
3Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan
4Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan

Correspondence should be addressed to Yuko Miyagoe-Suzuki; pj.og.pncn@eogayim

Received 11 December 2016; Revised 13 February 2017; Accepted 22 February 2017; Published 12 April 2017

Academic Editor: Gary E. Lyons

Copyright © 2017 Yuko Miyagoe-Suzuki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Soltanzadeh, M. J. Friez, D. Dunn et al., “Clinical and genetic characterization of manifesting carriers of DMD mutations,” Neuromuscular Disorders, vol. 20, no. 8, pp. 499–504, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Moser and A. E. Emery, “The manifesting carrier in Duchenne muscular dystrophy,” Clinical Genetics, vol. 5, no. 4, pp. 271–284, 1974. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Norman and P. Harper, “A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales,” Clinical Genetics, vol. 36, no. 1, pp. 31–37, 1989. View at Publisher · View at Google Scholar
  4. P. J. Taylor, S. Maroulis, G. L. Mullan et al., “Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy,” Journal of Medical Genetics, vol. 44, no. 6, pp. 368–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., “Induced pluripotent stem cell lines derived from human somatic cells,” Science, vol. 318, no. 5858, pp. 1917–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Tchieu, E. Kuoy, M. H. Chin et al., “Female human iPSCs retain an inactive X chromosome,” Cell Stem Cell, vol. 7, no. 3, pp. 329–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. Marchetto, C. Carromeu, A. Acab et al., “A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells,” Cell, vol. 143, no. 4, pp. 527–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Nakagawa, M. Koyanagi, K. Tanabe et al., “Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts,” Nature Biotechnology, vol. 26, no. 1, pp. 101–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Okita, Y. Matsumura, Y. Sato et al., “A more efficient method to generate integration-free human iPS cells,” Nature Methods, vol. 8, no. 5, pp. 409–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. W. Kimani, M. Shi, S. Daack-Hirsch et al., “X-chromosome inactivation patterns in monozygotic twins and sib pairs discordant for nonsyndromic cleft lip and/or palate,” American Journal of Medical Genetics Part A, vol. 143A, no. 24, pp. 3267–3272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Hosoyama, J. V. McGivern, J. M. Van Dyke, A. D. Ebert, and M. Suzuki, “Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture,” Stem Cells Translational Medicine, vol. 3, no. 5, pp. 564–574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. C. Allen, H. Y. Zoghbi, A. B. Moseley, H. M. Rosenblatt, and J. W. Belmont, “Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation,” American Journal of Human Genetics, vol. 51, no. 6, pp. 1229–1239, 1992. View at Google Scholar
  14. C. J. Brown, A. Ballabio, J. L. Rupert et al., “A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome,” Nature, vol. 349, no. 6304, pp. 38–44, 1991. View at Publisher · View at Google Scholar
  15. C. J. Brown, R. G. Lafreniere, V. E. Powers et al., “Localization of the X inactivation centre on the human X chromosome in Xq13,” Nature, vol. 349, no. 6304, pp. 82–84, 1991. View at Publisher · View at Google Scholar
  16. T. Bruck and N. Benvenisty, “Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells,” Stem Cell Research, vol. 6, no. 2, pp. 187–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Y. Kim, E. Hysolli, and I. H. Park, “Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 34, pp. 14169–14174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Y. Cheung, L. M. Horvath, D. Grafodatskaya et al., “Isolation of MECP2-null Rett syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation,” Human Molecular Genetics, vol. 20, no. 11, pp. 2103–2115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Ananiev, E. C. Williams, H. Li, and Q. Chang, “Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model,” PLoS One, vol. 6, no. 9, article e25255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Pomp, O. Dreesen, D. F. Leong et al., “Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase,” Cell Stem Cell, vol. 9, no. 2, pp. 156–165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. S. Barakat, M. Ghazvini, B. de Hoon et al., “Stable X chromosome reactivation in female human induced pluripotent stem cells,” Stem Cell Reports, vol. 4, no. 2, pp. 199–208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Tomoda, K. Takahashi, K. Leung et al., “Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells,” Cell Stem Cell, vol. 11, no. 1, pp. 91–99, 2012. View at Publisher · View at Google Scholar · View at Scopus